drugset / Trial / NCT00097734

Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis

NCT00097734

Phase 4 Unknown 540 enrolled Klinikum Hanover-Siloah Hospital
RandomizedParallel-groupOpen-labelEct

Summary

The purpose of this study is to compare the efficacy (by assessing the clinical success of treatment) of intravenous antibiotic therapy with ertapenem in patients with acute attacks of sigmoid diverticulitis for 4 vs. 7 days.

Timeline

Start
2004-07
Primary completion
Completion
2007-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ertapenem Small molecule Intravenous